VNS Therapy for Epilepsy - Since 1857, medications have been the first line of treatment to control seizures in people with epilepsy. While there has been considerable research and new drug developments,
![Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study - The Lancet Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study - The Lancet](https://www.thelancet.com/cms/attachment/2070050435/2067854863/gr1.gif)
Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study - The Lancet
![Which treatment strategy in patients with epilepsy with focal seizures uncontrolled by the first anti-seizure medication? - ScienceDirect Which treatment strategy in patients with epilepsy with focal seizures uncontrolled by the first anti-seizure medication? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1525505021002651-gr1.jpg)
Which treatment strategy in patients with epilepsy with focal seizures uncontrolled by the first anti-seizure medication? - ScienceDirect
![PDF] Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy | Semantic Scholar PDF] Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/aaa2aa01bedce63001c5b101b31c008efbb98bf2/3-Table1-1.png)
PDF] Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy | Semantic Scholar
![Focal abnormalities in idiopathic generalized epilepsy: A critical review of the literature - Seneviratne - 2014 - Epilepsia - Wiley Online Library Focal abnormalities in idiopathic generalized epilepsy: A critical review of the literature - Seneviratne - 2014 - Epilepsia - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/c0036032-5790-40c7-a4c6-bf7527a74cc2/epi.2014.55.issue-8.cover.jpg?trick=1682202389581)
Focal abnormalities in idiopathic generalized epilepsy: A critical review of the literature - Seneviratne - 2014 - Epilepsia - Wiley Online Library
![The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial - The Lancet The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial - The Lancet](https://www.thelancet.com/cms/attachment/1d0546dc-c3e6-4911-98cd-f06f2aec1f70/gr1.gif)